IgG1 and IgG2 are the predominant subclasses of antiphospholipid antibody in women with the lupus anticoagulant

Clinical Immunology and Immunopathology
D Dostal-JohnsonD W Branch

Abstract

We studied the sera of 36 patients with lupus anticoagulant and IgG antibodies against both phosphatidylserine and cardiolipin. Most sera also had IgG antibodies against other phospholipids: 97% against phosphatidylinositol, 91% against phosphatidylglycerol, and 82% against phosphatidylethanolamine. IgG2 was the predominant subclass against cardiolipin and phosphatidylserine; 35 of 36 patients (98%) had IgG2 against both phospholipids. Most patients also had the IgG1 subclass; 32 of 36 (89%) against cardiolipin and 25 of 36 (69%) against phosphatidylserine. IgG3 and IgG4 subclasses were present at very low concentrations and in only a minority of the sera. The antibody response against phosphatidylserine was characterized by significantly less IgG1 than was the response against cardiolipin (P less than 0.01), although the IgG2 responses against each phospholipid were not different. IgG subclasses were unrelated to any other aspect of the patients' history, including a history of thrombocytopenia or thrombosis, a positive antinuclear antibody test, or a diagnosis of systemic lupus erythematosus.

References

Aug 1, 1978·Clinical Immunology and Immunopathology·R D Sontheimer, J N Gilliam
Jan 1, 1987·Clinical Immunology and Immunopathology·D W BranchJ R Scott
Jan 22, 1988·JAMA : the Journal of the American Medical Association·D A TriplettC A Orr
Apr 1, 1985·The Journal of Clinical Investigation·R A EisenbergW J Yount
Nov 21, 1985·The New England Journal of Medicine·D W BranchE Hershgold
Nov 1, 1973·Clinical Immunology and Immunopathology·S KarpatkinG W Siskind
Mar 1, 1972·Arthritis and Rheumatism·P H SchurN Rothfield
Nov 10, 1984·Lancet·E N HarrisG R Hughes
Mar 1, 1984·Archives of Internal Medicine·M Elias, A Eldor
Apr 1, 1984·British Journal of Obstetrics and Gynaecology·W F LubbeG C Liggins
Feb 1, 1980·Annals of Internal Medicine·J R MuehS I Rapaport

❮ Previous
Next ❯

Citations

Dec 3, 2014·The American Journal of Pathology·Yuan-Yuan WuElaine Y Lin
Nov 1, 1990·Clinical Immunology and Immunopathology·M M Ward, D S Pisetsky
Jul 10, 2003·Clinics in Laboratory Medicine·Neal S Rote, Bradley P Stetzer
Apr 2, 1999·American Journal of Reproductive Immunology : AJRI·W H KuttehR Silver
Apr 1, 1996·American Journal of Reproductive Immunology : AJRI·N S Rote
Sep 1, 1991·Scandinavian Journal of Immunology·U TiikkainenD Arthur
Jan 30, 2004·American Journal of Reproductive Immunology : AJRI·Shelly Tartakover MatalonAsher Ornoy
Feb 1, 1994·Clinical and Experimental Immunology·J ArvieuxM G Colomb

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antiphospholipid Syndrome

Antiphospholipid syndrome or antiphospholipid antibody syndrome (APS or APLS), is an autoimmune, hypercoagulable state caused by the presence of antibodies directed against phospholipids.

Blood Clotting Disorders

Thrombophilia includes conditions with increased tendency for excessive blood clotting. Blood clotting occurs when the body has insufficient amounts of specialized proteins that make blood clot and stop bleeding. Here is the latest research on blood clotting disorders.